Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C. London
The Bromodomain BET Inhibitor JQ1 Suppresses Tumor Angiogenesis in Models of Childhood Sarcoma
Molecular Cancer Therapeutics
Cancer Research
Oncology
Treatment of Canine Osseous Tumors With Photodynamic Therapy: A Pilot Study
Clinical Orthopaedics and Related Research
Medicine
Surgery
Orthopedics
Sports Medicine
Sports Science
Related publications
BET Protein Inhibitor JQ1 Downregulates Chromatin Accessibility and Suppresses Metastasis of Gastric Cancer via Inactivating RUNX2/NID1 Signaling
Oncogenesis
Cancer Research
Molecular Biology
JQ1 Suppresses Tumor Growth Through Downregulating LDHA in Ovarian Cancer
Oncotarget
Oncology
The BET-bromodomain Inhibitor JQ1 Renders Neuroblastoma Cells More Resistant to NK Cell-Mediated Recognition and Killing by Downregulating Ligands for NKG2D and DNAM1 Receptors
Oncotarget
Oncology
Targeting the IGF1R/PI3K/AKT Pathway Sensitizes Ewing Sarcoma to BET Bromodomain Inhibitors
Molecular Cancer Therapeutics
Cancer Research
Oncology
Preclinical Evaluation of the BET Bromodomain Inhibitor BAY 1238097 for the Treatment of Lymphoma
British Journal of Haematology
Hematology
Affinity Map of Bromodomain Protein 4 (BRD4) Interactions With the Histone H4 Tail and the Small Molecule Inhibitor JQ1
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
BET Bromodomain Inhibition Enhances T Cell Persistence and Function in Adoptive Immunotherapy Models
Journal of Clinical Investigation
Medicine
JQ1, an Inhibitor of the Epigenetic Reader BRD4, Suppresses the Bidirectional MYC-AP4 Axis via Multiple Mechanisms
Oncology Reports
Medicine
Cancer Research
Oncology
BET Bromodomain Proteins Are Therapeutic Targets in CRPC
Cancer Discovery
Oncology
